We previously reported that a recombinant genome derived from the autonomous rodent parvovirus Lulll could be pseudotyped with capsids of the closely related viruses, H 1 and minute virus of mice. To determine whether this was also possible with less related viruses, Lulll recombinant genomes containing a luciferase reporter were cotransfected into permissive cells together with plasmids expressing the capsid proteins of either feline panleukopenia virus (FPV) or its host range variant, canine parvovirus (CPV). We observed efficient packaging of the recombinant DNA into transducing virions that displayed the cell tropism of the virus that supplied the capsid. Thus, the FPV-and CPVpseudotyped virions were able to transduce a feline cell line but they showed no transducing activity for the human NB324K line, which is permissive for Lulll. The transducing activity of the pseudotyped viruses was not inhibited by neuraminidase treatment of the permissive recipient cells, in contrast to that of virions packaged using Lulll capsid proteins. Furthermore, canine A72 cells (permissive for CPV but not FPV) were efficiently transduced by CPVpackaged but not by FPV-packaged Lulll recombinant genomes. Pseudotyped recombinants will be useful for elucidating parvovirus host range determinants since they enable the packaged DNA and each of the capsid proteins to be supplied independently. They should also facilitate control over the targeting of parvovirus vectors for gene transfer.
Introduction
We previously described the production of transducing recombinant virions derived from the rodent parvovirus, LuIII, with substitution of reporter genes for the viral coding sequences (Maxwell et aI., 1993 a, b) . The recombinant genome could be packaged by capsid proteins either from LuIII or from closely related parvoviruses. Such pseudotyped virions have proven useful in investigating determinants of host range and DNA strand packaging of rodent parvoviruses (Maxwell eta]., 1993 (Maxwell eta]., b, 1995 Corsini et a]., 1995) . This report extends these studies by showing that recombinant LuIII genomes can also be packaged by capsid proteins from somewhat more distantly related parvoviruses.
The feline group of autonomous parvoviruses includes canine parvovirus (CPV) and mink enteritis virus (MEV), both of which have apparently arisen as host range variants of feline Author for correspondence: lan H. Maxwell.
Fax + 1 303 270 8272. e-mail lan.Ma×well@uchsc.edu panleukopenia virus (FPV) (Siegl et al., 1985) . CPV first appeared in the late 1970s and has continued to evolve (Truyen et aI., 1995) . These viruses have a similar genetic organization to the rodent parvoviruses, to which they show an overall DNA sequence identity of ~ 65 % (Carlson et al., 1985 ; Martyn eta] ., 1990). In cell culture, CPV can productively infect both canine and feline cell lines whereas FPV is restricted to feline cells. However, a more complex pattern of in vivo tropisms has been demonstrated in dogs and cats infected with these viruses (Truyen eta]., 1992) . Here, we show that recombinant LulII genomes can be pseudotyped by capsid proteins of both FPV and CPV. The resulting virions transduced cultured feline or canine cells with the specificity of the respective viruses that supplied the capsid.
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I llll -FPV VP1NP2 pF-VP Fig. 1 . Structure of the plasmids used for cotransfections. The LuLII recombinant constructs, pGLuP4LUC1 and pGLuPS8LUC2, are shown in the top two rows. The lower four rows show plasmids designed to express Lull) non-structura) proteins, or Lu))), CPV or FPV capsid proteins. Black bars indicate parvovirus terminal palindromes (not drawn to scale). P4, P38: the parvoviral promoters located at 4 and 38 map units in the wildtype genomes. RSV: Rous sarcoma virus promoter. ATG: initiation codon for VP2. TAA: termination codon for VP1 and VP2. An: polyadenylation signal. Numbers refer to nucleotide position in the Lulll sequence (Diffoot et el., 1993) .
fibroma-derived (Binn et al., 1980) cells were kindly supplied by J. O. Carlson and C. R. Parrish, respectively. Cells were maintained in Opti-MEM (GIBCO) with 3"8% fetal bovine serum.
• Plasmids. The structures of the transducing genomes, in plasmids pGLuP4LUC1 and pGLuP38LUC2, and of the helper constructs are shown in Fig. 1 . The construction of pGLuP4LUC1 (previously designated pGLuLUCASV) has been described (Maxwell et al., I993 b) . This plasmid retains the LulII terminal inverted repeat sequences and the P4 promoter, which drives expression of a luciferase reporter, substituted for the viral non-structural (NS) and capsid (VP) coding sequences. pGLuP38LUC2, derived by replacement of only the VP2 coding region by the luciferase gene, is analogous to the MVM derived transducing recombinants described by Russell et al. (1992) and Dupont et at. (1994) . Because pGLuP38LUC2 retains the full sequence for the NS proteins it can express the NS1 protein required for DNA amplification and P38 transactivation. Therefore, only a VP-expressing helper plasmid is necessary for recombinant virus production from pGLuP38LUC2 in transfected cells. [n contrast, pGLuP4LUCI requires an NS expression plasmid (pRSVhel) as well as a source of capsid proteins, pGLuP38LUC2 was made by substituting a PstI-HindlII fragment (including LuIII nt 1-2652; Diffoot eta[., 1993) from pGLu883AXba (Maxwell et al., I993 b) for the corresponding fragment of pGLP (Maxwel| et ~I., 1996) . The helper plasmid, pRSVhel, expressing LuIII non-structural proteins, was constructed by insertion of a LuIt[ fragment (nt 265-4287) into the Notl site of pREP8 (Invitrogen). This placed the LuIIl NS1/NS2 gene downstream from the Rous sarcoma virus (RSV) long terminal repeat. The capsid protein expression plasmids, pLuVP, pC-VP and pF-VP, contain the P38 promoter and complete capsid coding sequences of LulII, CPV and FPV, respectively. They are replication-defective owing to deletion of the left-terminus and ~ 0-8-10 kb of the NS protein coding region, pLuVP was made by deletion of a PstI-Bg]ll fragment from pGluABE (Hanson & Rhode, 1991) , removing nt 1-1250 of the LuIII genome, pC-VP was made by deletion of a Bc~mHI-EcoRI fragment from pBId07 (Barbis et a] ., I992), an infectious CPV plasmid kindly supplied by C. R. Parrish. This removed the non-structural coding sequence to the left of the EcoRI site (nt 1098). It should be noted that the CPV capsid sequence encoded in pBD07, and hence pC-VP, contains a point mutation (Arg --* Lys at residue 377 of VP2) that abrogates haemagglutination and sialic acid binding (Parrish et al., 1988; Barbis et al., 1992) . pF-VP is a subclone in pUC18 of the FPV EcoRl fragment from pEH20 (Carlson et aL, 1985) ; this plasmid contains FPV nt 1099-5040. Standard cloning and purification methods were employed (Maniatis et al., 1982; Maxwell et al., 1986) . Plasmids containing the transducing genomes were propagated in Escherichia coli strain SURE (Stratagene) and helper plasmids were grown in strain HB101.
• Transfection and infection. Recombinant viruses were generated as described (Maxwell eta/., i993 b) by cotransfection of NB324K cells. Samples of cell suspensions (~ 1"0 x I0 v cells/ml) were electroporated with pGLuP4LUC1 (25 l~g/ml) plus pRSVhel (10 i~g/ml) or with pGLuP38LUC2 (35 ~g/ml), together with one of the plasmids providing capsid proteins (40 }ag/ml). The plasmids were transfected in their covalently closed circular form. The pulsed cells were cultured overnight in medium with I0% fetal bovine serum which was then changed for maintenance medium. Transducing virus was harvested 3-4 days following electroporation by combining the culture medium with an extract of the cells made by freezing and thawing three times. After lowspeed centrifugation, the resulting viral supernatants were stored at -20 °C. The transducing activity of the recombinant viruses was determined (Maxwell et al., I993 a, b) by assaying Iuciferase expression in recipient cells at an appropriate time following infection. Thus, NB324K, CFK or A72 cells were grown to ~ 30% confluence in 6 cm diameter dishes, were then infected and luciferase activity was measured in extracts of these recipient cells prepared at ~ 48 h post-infection.
• Luciferase assays. Standard assays were performed as described (de Wet et el., 1987; Maxwell & Maxwell, 1988) ; alternatively, the Promega luciferase assay system was used according to the manufacturer's instructions, giving ~ 5-fold higher light units than the standard assay. Samples were assayed using 10 s integration on either an Ortocomp or Analytical Luminescence tuminometer.
• PCR. Vent DNA polymerase (0"01 units; New England Biolabs) was used in the presence of 0"2 mM each of dATP, dGTP, dCTP and dTTP and 1,M of each primer, in a volume of 25,1 in the enzyme manufacturer's recommended buffer. The luciferase primers were LK1 (upstream) and LK2 (downstream), whose sequences are 5' GGATG-GAACCGCTGGAGAGC 3' and 5' GTGACGAACGTGTACATCGA-CTG 3'. Amplification was performed in a hot air oven (Biotherm Inc.) with the following thermal profile: 2 min at 94 °C; 30 cycles of 30 s at 94 °C, 1'5 min at 55 °C, 2 min at 72 °C; final 7 min at 72 °C. 
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Results
To determine whether the recombinant LuIII genomes shown in Fig. 1 could be packaged by CPV and FPV, plasmids containing these genomes were transfected into NB324K cells together with expression plasmids for the capsid proteins of either LuIII, CPV or FPV (pLuVP, pC-VP and pF-VP, respectively; also shown in Fig. 1 ) and, where necessary, with a separate expression plasmid (pRSVhel) for the non-structural proteins of LuIII. Initial results (not shown) indicated that transducing LuIII virions were generated from such triple cotransfections using pLuVP with an efficiency up to ~ 50% of that observed in transfections using a single helper plasmid supplying both LuIII non-structural and capsid proteins. Medium plus cell extract from the transfected cells was overlaid on subconfluent NB324K or CFK cells. Extracts of these recipient cells, prepared ~ 48 h post-infection were assayed for luciferase activity. As shown in Table 1 , LuIIIencapsidated viruses expressed high levels of transduced luciferase in NB324K cells, as was expected from previous results (Maxwell et a] ., 1993 a, b). The LulII capsid also allowed T a b l e 1. T r a n s d u c t i o n of h u m a n and feline cells by virions c o n t a i n i n g a Lulll r e c o m b i n a n t g e n o m e , p a c k a g e d * NB324K producer cells were cotransfected with the plasmid containing the LuIII recombinant genome and the capsid expression plasmid indicated. A third pIasmid, pRSVheI, was incIuded in the cotransfections with pGLuP4LUCI in order to supply LuIII nonstructural proteins (see Methods). t-Luciferase activity was determined in extracts of recipient ceils prepared ~ 48 h following their infection with virus supematants (0"3 ml per 6 cm diameter dish) from producer cells expressing the indicated capsid. Values given are the mean ± standard deviation for four determinations. Standard and Promega luciferase assays were used, respectively, for NB324K and CFK extracts. :1: The substantially higher transducing activity of GLuP38LUC2 compared with GLuP4LUC1 is presumably due to genome amplification and transactivation of the P38 promoter by the NS1 protein expressed in recipient cells from this transducing genome. transduction of CFK (feline) cells, although with considerably lower efficiency (Table 1 , first row). Substantial luciferase activity was also seen in CFK cells exposed to extracts from producer cells that had received either the CPV or FPV capsid expression plasmid (Table 1 ), confirming that transducing virions had been generated under these conditions. In contrast, these extracts showed no transducing activity in NB324K cells, a result consistent with the inability of CPV and FPV to infect human cells. To substantiate the inferred packaging of the recombinant LuIII genomes into CPV and FPV capsids and to compare efficiency with the homologous LuIII capsid, we performed PCR assays for the packaged GLuP4LUC1 genome. This was done by exposure of samples of medium plus cell extracts from the producer cells to extensive DNase treatment, followed by PCR with luciferase primers. As shown in Fig. 2 , transfection with each of the three helper constructs gave rise to PCR signals of comparable intensity. Without a helper plasmid providing capsid proteins (lane 4), only a trace of DNA was detected (probably residual plasmid that escaped DNase). These results confirmed that virions were generated from the recombinant LulII genome using the non-structural proteins of LuIII, together with the capsid proteins of either LuIII, CPV or FPV, and indicated a similar efficiency of encapsidation in each case.
It is well established that cells can be protected from infection by certain parvoviruses (e.g. minute virus of mice, MVM) by neuraminidase treatment (Cotmore & Tattersall, 1989) , implying that surface sialic acid residues contribute to the receptor for these viruses. We have confirmed that this is also true for LuIII infection of human cells (unpublished observation). There is evidence that infection of at least some cells by viruses of the feline subgroup is insensitive to neuraminidase even though CPV and FPV are capable of binding sialic acid residues (Barbis et al., i992). We therefore expected that transduction by the CPV-and FPV-encapsidated LulII recombinant viruses would not be inhibited by treatment of recipient cells with neuraminidase, whereas transduction by recombinants packaged with LulII capsid should be abolished. As shown in Fig. 3 , treatment of CFK cells with neuraminidase indeed prevented their transduction by the LulII-encapsidated virus but not by the CPV-or FPV-encapsidated viruses. In fact, this treatment substantially stimulated transduction by the FPV-encapsidated virus (see Discussion). These observations of respective neuraminidase sensitivity or resistance of transduction by recombinant viruses generated using LulII or FPV/CPV capsid helpers further substantiate the conclusion that the latter capsids are functional in packaging recombinant LulII genomes. The availability of a recombinant LullI genome packaged in capsid from either CPV or FPV allowed us to investigate whether the capsid of such pseudotyped viruses would impose the cell tropism of the parental virus with respect to feline versus canine cells. For this, we used the CFK feline cell line, which is permissive for both CPV and FPV, in comparison with the A72 canine cell line, which is permissive for CPV but not for FPV (Binn ef al., 1980) . As shown in Fig. 4 , both the CPVand laPV-pseudotyped viruses were capable of transducing CFK cells. The CPV-packaged viruses were, however, somewhat less efficient. In contrast, in canine A72 cells transducing activity was at least 20-fold higher for the viruses pseudotyped by CPV than by FPV. This result demonstrates that recombinant LuIII virions pseudotyped in CPV or FPV capsids largely retain the cell tropism of the virus that supplied the capsid proteins.
Discussion
We previously demonstrated encapsidation of a LuIIIderived recombinant genome with H1 and MVM capsid proteins (Maxwell et aI., 1993a) . We now report that such encapsidation can also be achieved using capsid proteins from the less closely related parvoviruses, CPV and FPV. The amino acid sequence identity between the major capsid protein, VP2, of LulII and MVM is ~ 73 %, while identity between VP2 of LulII and CPV is ~ 54 % (Reed et aI., 1988; Diffoot ef al., 1993) . Despite this relatively low identity, PCR amplification of DNase-treated virus supernatants indicated similar packaging efficiency of the LulII-recombinant genome with LuIII, CPV and FPV.
The viruses pseudotyped with CPV or FPV capsids were able to transduce feline cells (CFK) but they did not transduce human cells, in contrast to the H1 and MVM pseudotypes. Neuraminidase treatment of recipient cells essentially abolished transduction by the LulII-encapsidated virus. In contrast, the corresponding FPV-pseudotyped virus showed an ~ 5-fold increase in transduced luciferase activity in neuraminidasetreated CFK cells compared with the untreated cells. This suggests that cell surface sialic acid residues may hinder binding of the FPV capsid to a functional receptor. The transducing activity of virus packaged with the CPV-capsid helper plasmid was not increased by neuraminidase to the extent seen with the FPV capsid, possibly because our CPV capsid was derived from the non-haemagglutinating mutant virus vBId07 (see Methods). Although the receptor for FPV/CPV has not been characterized, Barbis et al. (1992) have identified cell membrane proteins capable of binding CPV in a neuraminidase-resistant manner. Barbis et al. (1992) reported that FPV plaque formation on feline NLFK cells was unaffected by neuraminidase treatment. However, Basak et at. (I994) observed partial inhibition of CPV infection of neuraminidasetreated canine A72 cells, assayed by immunofluorescence. These apparent discrepancies may relate to the use of different cell lines, treatment conditions, or sources of neuraminidase.
The host range determinants of FPV versus CPV have been mapped to two or three specific amino acid residues in the capsid proteins (Chang et aI., 1992) . The analogous allotropic determinants of the fibrotropic and lymphotropic strains of 9( minute virus of mice (MVMp and MVMi) have similarly been mapped to specific residues in the capsid (Antonietti et a] ., Ball-Goodrich & Tattersall, 1992) . In both systems, the primary blockage in restrictive host cells appears to occur after penetration but prior to viral transcription (Gardiner & Tattersall, 1988; Horiuchi et al., 1992) . In previous studies we showed that transducing virions, pseudotyped with capsid proteins of either MVMp or MVMi, retained the tropism of the virus that supplied the capsid (Maxwell eta] ., 1993a; unpublished observations) and we further demonstrated that this property was dependent on the major capsid protein (Maxwell et at., 1995) . Our present results show that, in FPVand CPV-pseudotyped recombinants also, the capsid proteins are sufficient to confer cell tropism (arguing against any necessary cis-acting function of the encoding DNA). Thus, the CPV-encapsidated virions were able to transduce both feline and canine cells efficiently. The FPV-pseudotyped viruses, however, showed high transducing activity only in the feline cells. Although A72 cells expressed significant luciferase from the more active P38 construct packaged by FPV, this activity was < 5 % of that seen for the same construct packaged by CPV. It should be noted that, in our experiments, luciferase activity is dependent only on transcription of the transducing genome and our results do not exclude possible additional blockages at later stages in infection by wild-type viruses under restrictive conditions.
Pseudotyping of recombinant parvoviruses may be useful in manipulating their transducing host range. Previously, we discussed the possibility of using recombinant parvoviruses as transient gene transfer vectors (Maxwell et a] ., 1993 b) with further modification enabling tissue-specific or inducible expression (Maxwell et al., 1996) . We have now produced recombinants packaged in capsids that do not permit infection of human cells. Since the structure of the CPV capsid is understood in considerable detail (Tsao et al., 1991) , it may be possible to design capsid protein modifications enabling targeting of specific human cell types, with potential applications in gene therapy. 
